廣州太二餐飲:與央視報道涉及酸菜生產企業沒有合作關係
廣州太二餐飲發表聲明指,公司與央視315報道中,涉及的酸菜生產企業沒有合作關係,又表示現時使用的酸菜供應商為四川民福記食品有限公司和吉香居食品股份有限公司,兩家企業均具備醬醃菜生產許可資質。
公司表示,每一批酸菜均經過出廠檢測,且不定期送至第三方檢測,檢測結果符合相關標準後方才使用。同時,公司已成立工作小組,於第一時間前往供應商處,將全面檢查並監督供應商全部生產環節確保酸菜符合相關食品安全標準。
在3月15日晚上,央視315晚會曝光了企業利用收購來的「土坑酸菜」 代加工酸菜製品,這些企業為一些方便麵企業代加工老壇酸菜包。 「土坑酸菜」生產環節不符合食品衛生標準,也並未進行衛生指標檢測。(ca/u)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.